Merck launches Biosimilars Clarified, a new online educational resource about biosimilar medicines f
Merck (NYSE:MRK), known as MSD outside the United States and Canada, has announced the launch of Biosimilars Clarified, a new educational website for patients, caregivers and the healthcare community that is designed to provide clear, concise and straightforward information about biosimilar medicines.
Click on this link for more information.
